SEARCH

SEARCH BY CITATION

References

  • Alberti KGMM, Zimmet PZ & Consultation WHO (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabetic Medicine 15, 539553.
  • Alisjahbana B, Sahiratmadja E, Nelwan EJ et al. (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical Infectious Diseases 45, 428435.
  • Baker MA, Harries AD, Jeon CY et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Medicine 9, 81.
  • Başoğlu OK, Bacakoğlu F, Cok G, Sayiner A & Ateş M (1999) The oral glucose tolerance test in patients with respiratory infections. Monaldi Archives for Chest Disease 54, 307310.
  • Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ & Cooper DA (1999) Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study. The Lancet 353, 20932099.
  • Dooley KE & Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 9, 737746.
  • Dooley KE, Tang T, Golub JE, Dorman SE & Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. American Journal of Tropical Medicine and Hygiene 80, 634639.
  • Faurholt-Jepsen D, Range N, PrayGod G et al. (2011) Diabetes is a risk factor for pulmonary tuberculosis: a case–control study from Mwanza, Tanzania. PLoS ONE 6, e24215.
  • Faurholt-Jepsen D, Range N, PrayGod G et al. (2012) The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Tropical Medicine & International Health 17, 877883.
  • Gearhart MM & Parbhoo SK (2006) Hyperglycemia in the critically ill patient. AACN Clinical Issues 17, 5055.
  • Griesdale DEG, De Souza RJ, Van Dam RM et al. (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Canadian Medical Association Journal 180, 821827.
  • Güler M, Ünsal E, Dursun B, AydIn Ö Capan N (2007) Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. International Journal of Clinical Practice 61, 231235.
  • IUATLD (2000) Technical Guide: Sputum Examination for Tuberculosis by Direct Microscopy in Low Income Countries, 5th edn. International Union Against Tuberculosis and Lung Disease (IUATLD), Paris.
  • Jeon CY & Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine 5, e152.
  • Jeon CY, Harries AD, Baker MA et al. (2010) Bi-directional screening for tuberculosis and diabetes: a systematic review. Tropical Medicine and International Health 15, 13001314.
  • Kuhnlein H & Receveur O (1996) Dietary change and traditional food systems of indigenous peoples. Annual Review of Nutrition 16, 417442.
  • Lin DY, Wei LJ & Ying Z (1993) Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80, 557572.
  • Mboussa J, Monabeka H, Kombo M, Yokolo D, Yoka-Mbio A & Yala F (2003) Evolution de la tuberculose pulmonaire chez les diabétiques. Revue de Pneumologie Clinique 59, 3944.
  • Nijland HMJ, Ruslami R, Stalenhoef JE et al. (2006) Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clinical Infectious Diseases 43, 848854.
  • Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS & Chaisson RE (2002) Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clinical Infectious Diseases 34, 752759.
  • Patel J, De Souza C & Jigjini S (1977) Diabetes and tuberculosis. Indian Journal of Tuberculosis 24, 155158.
  • PrayGod G, Range N, Faurholt-Jepsen D et al. (2011) Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. The Journal of Nutrition 141, 685691.
  • PrayGod G, Range N, Faurholt-Jepsen D et al. (2012) The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania. British Journal of Nutrition 107, 19.
  • Restrepo BI, Fisher-Hoch SP, Crespo JG et al. (2007) Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiology and Infection 135, 483491.
  • Roglic G & Unwin N (2010) Mortality attributable to diabetes: estimates for the year 2010. Diabetes Research and Clinical Practice 87, 1519.
  • Ruslami R, Aarnoutse RE, Alisjahbana B, Van Der Ven AJAM & Van Crevel R (2010a) Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health 15, 12891299.
  • Ruslami R, Nijland HMJ, Adhiarta IGN et al. (2010b) Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes. Antimicrobial Agents and Chemotherapy 54, 10681074.
  • Sasaki Y, Yamagishi F, Yagi T et al. (2003) A study on pulmonary tuberculosis retreatment cases. Kekkaku 78, 723732.
  • Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA & Osman MM (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. International Journal of Tuberculosis and Lung Disease 10, 7479.
  • Torun B, Stein AD, Schroeder D et al. (2002) Rural-to-urban migration and cardiovascular disease risk factors in young Guatemalan adults. International Journal of Epidemiology 31, 218226.
  • Wang JY, Lee LN & Hsueh PR (2005) Factors changing the manifestation of pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease 9, 777783.
  • Wang CS, Yang CJ, Chen HC et al. (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiology and Infection 137, 203210.
  • Whiting DR, Guariguata L, Weil C & Shaw J (2011) IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94, 311321.
  • WHO(2006) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia. Geneva, Switzerland: http://www.who.int/diabetes/publications/en/ (Accessed 12 March 2009).
  • WHO. Treatment of Tuberculosis: guidelines for national programmes. http://www.who.int/tb/publications/tb_treatmentguidelines/en/index.html (Accessed 12 August 2012).
  • Yajnik CS (2004) Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. Journal of Nutrition 134, 205210.
  • Young F, Critchley JA, Johnstone LK & Unwin NC (2009) A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Globalization and Health 5, 9.